- Home
- RR vs BDTX Comparison
RR vs BDTX Comparison
Compare RR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RR
- BDTX
- Stock Information
- Founded
- RR 2016
- BDTX 2014
- Country
- RR United States
- BDTX United States
- Employees
- RR N/A
- BDTX N/A
- Industry
- RR
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RR
- BDTX Health Care
- Exchange
- RR Nasdaq
- BDTX Nasdaq
- Market Cap
- RR 213.5M
- BDTX 181.4M
- IPO Year
- RR 2023
- BDTX 2020
- Fundamental
- Price
- RR $2.21
- BDTX $2.76
- Analyst Decision
- RR Strong Buy
- BDTX Strong Buy
- Analyst Count
- RR 1
- BDTX 5
- Target Price
- RR $3.50
- BDTX $13.40
- AVG Volume (30 Days)
- RR 9.5M
- BDTX 902.5K
- Earning Date
- RR 08-11-2025
- BDTX 08-07-2025
- Dividend Yield
- RR N/A
- BDTX N/A
- EPS Growth
- RR N/A
- BDTX N/A
- EPS
- RR N/A
- BDTX 0.25
- Revenue
- RR $4,126,000.00
- BDTX $70,000,000.00
- Revenue This Year
- RR $36.86
- BDTX N/A
- Revenue Next Year
- RR $113.58
- BDTX N/A
- P/E Ratio
- RR N/A
- BDTX $11.03
- Revenue Growth
- RR N/A
- BDTX N/A
- 52 Week Low
- RR $0.48
- BDTX $1.20
- 52 Week High
- RR $5.20
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- RR 61.00
- BDTX 52.31
- Support Level
- RR $1.81
- BDTX $2.22
- Resistance Level
- RR $1.95
- BDTX $2.84
- Average True Range (ATR)
- RR 0.14
- BDTX 0.20
- MACD
- RR 0.04
- BDTX -0.01
- Stochastic Oscillator
- RR 78.18
- BDTX 72.00
About RR Richtech Robotics Inc. Class B
Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designs, manufacture and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.